DeepMed Research

CORDIS CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Multi-center Post-Market Surveillance Registry

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Device: drug-eluting stent

First Posted Date: 2007-02-22

Last Posted Date: 2009-12-03

Lead Sponsor: Cordis Corporation

Target Recruit Count: 15000

Registration Number: NCT00438919

Locations: 🇨🇭
Clinique La Tour, Meyrin, Switzerland

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Completed

Conditions: Carotid Artery Disease

First Posted Date: 2006-11-23

Last Posted Date: 2020-08-10

Lead Sponsor: Cordis Corporation

Target Recruit Count: 21008

Registration Number: NCT00403078

Locations: 🇺🇸
The Heart Center, PC, Kingsport, Tennessee, United States
🇺🇸
Iowa Clinic, Heart & Vascular Care, West Des Moines, Iowa, United States
🇺🇸
Harrisburg Hospital, Harrisburg, Pennsylvania, United States

and more 2 locations

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Completed

Conditions: Coronary Stenosis

First Posted Date: 2006-11-23

Last Posted Date: 2009-10-07

Lead Sponsor: Cordis Corporation

Target Recruit Count: 1500

Registration Number: NCT00403338

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: bare-metal stent
Device: drug-eluting stent

First Posted Date: 2006-09-27

Last Posted Date: 2008-10-31

Lead Sponsor: Cordis Corporation

Target Recruit Count: 100

Registration Number: NCT00381420

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Phase 3

Completed

Conditions: Peripheral Arteriosclerosis
Angioplasty, Transluminal, Percutaneous Coronary
Coronary Arteriosclerosis

Interventions: Device: Vascular Closure Device
Other: Manual Compression

First Posted Date: 2006-06-28

Last Posted Date: 2012-06-01

Lead Sponsor: Cordis Corporation

Target Recruit Count: 488

Registration Number: NCT00345631

Locations: 🇺🇸
Wake Heart Research, Raleigh, North Carolina, United States
🇺🇸
Hahnemann Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
University Hospitals of Cleveland, Cleveland, Ohio, United States

and more 14 locations

The Intra-Drug Eluting Stent (DES) Restenosis Study

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Device: drug-eluting stent and balloon angioplasty
Device: drug-eluting stent

First Posted Date: 2006-05-10

Last Posted Date: 2010-07-29

Lead Sponsor: Cordis Corporation

Target Recruit Count: 320

Registration Number: NCT00323895

Locations: 🇫🇷
Centre Cardiologique du Nord, Saint Denis, France
🇫🇷
Unite de Cardiologie Interventionelle, Toulouse Cedex 3, France

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Phase 3

Completed

Conditions: Coronary Disease

Interventions: Device: Corio™ Pimecrolimus-Eluting Coronary Stent System
Device: SymBio™ Pimecrolimus/Paclitaxel-Eluting Coronary Stent System
Device: Costar ™ Paclitaxel-Eluting Coronary Stent System

First Posted Date: 2006-05-08

Last Posted Date: 2013-03-06

Lead Sponsor: Cordis Corporation

Target Recruit Count: 246

Registration Number: NCT00322569

Locations: 🇬🇧
Southampton University Hospital, Southampton, United Kingdom

The Study to Compare SMART Nitinol Stent and Balloon Angioplasty

Phase 4

Completed

Conditions: Superficial Femoral Artery Occlusions

Interventions: Device: stent
Device: balloon

First Posted Date: 2006-04-03

Last Posted Date: 2009-06-12

Lead Sponsor: Cordis Corporation

Target Recruit Count: 50

Registration Number: NCT00309595

Locations: 🇨🇭
University Hospital Zurich, Zurich, Switzerland
🇨🇭
Univeristy Hospital Bern, Bern, Switzerland

The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.

Phase 4

Terminated

Conditions: Arterial Occlusive Diseases

Interventions: Device: stent
Device: angioplasty

First Posted Date: 2006-02-09

Last Posted Date: 2009-02-24

Lead Sponsor: Cordis Corporation

Target Recruit Count: 10

Registration Number: NCT00289055

Locations: 🇳🇱
AMC, Amsterdam, Netherlands

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.

Phase 2

Completed

Conditions: Coronary Artery Disease

Interventions: Device: emboli capturing guidewire device combined with stent

First Posted Date: 2005-12-12

Last Posted Date: 2008-08-06

Lead Sponsor: Cordis Corporation

Target Recruit Count: 100

Registration Number: NCT00264043

Locations: 🇩🇪
Herzzentrum Siegburg GMBH, Siegburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy